SV2B Antikörper (AA 2-17)
Kurzübersicht für SV2B Antikörper (AA 2-17) (ABIN1742257)
Target
Alle SV2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 2-17
-
Spezifität
- Specific for SV2 B.
-
Immunogen
- Synthetic peptide DDYRYRDNYEGYAPND (aa 2-17 in rat) coupled to key-hole limpet hemocyanin via an added N-terminal cysteine residue.
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- WB: 1:1000 , ICC: 1:2000 up to 1:5000, IHC: 1:200 up to 1:500,
-
Kommentare
-
WB: SV2 aggregates after boiling, making it necessary to run SDS-PAGE only with non-boiled samples.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- For reconstitution add 100µl H2O to get a 1mg/ml solution in PBS.
-
Buffer
- PBS. Albumin and azide were added for stabilization.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Do not freeze! Antibodies should be stored at +4°C when still lyophilized.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Reconstitute and aliquot and store at -20°C to -80°C until use. Antibodies should be stored at +4°C when still lyophilized.
-
-
-
: "BDNF modulates glycine uptake in hippocampal synaptosomes by decreasing membrane insertion of glycine transporter 2." in: Neurochemistry international, Vol. 99, pp. 94-102, (2016) (PubMed).
: "Loss of photoreceptors results in upregulation of synaptic proteins in bipolar cells and amacrine cells." in: PLoS ONE, Vol. 9, Issue 3, pp. e90250, (2014) (PubMed).
-
: "BDNF modulates glycine uptake in hippocampal synaptosomes by decreasing membrane insertion of glycine transporter 2." in: Neurochemistry international, Vol. 99, pp. 94-102, (2016) (PubMed).
-
- SV2B (Synaptic Vesicle Glycoprotein 2B (SV2B))
-
Andere Bezeichnung
- SV2 B
Target
-